Skip to content

Early Palliative Care Integration in Interventional Cancer Care

Early Palliative Care Integration in Interventional Cancer Care

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03185416
Acronym
EPIICC
Enrollment
0
Registered
2017-06-14
Start date
2018-08-01
Completion date
2019-08-01
Last updated
2018-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Colon, Cancer Liver, Palliative Care

Keywords

Quality of Life, Caregiver, Quality Improvement

Brief summary

A mixed methods randomized control trial assessing the impact of early palliative care incorporation in liver cancer and metastatic colorectal cancer on caregiver well-being, patient physical and psychosocial outcomes, and health services utilization.

Detailed description

The purpose of this project is to conduct a mixed-methods study of the impact of early integration of palliative care in interventional oncology on three outcomes of interest: 1\) caregiver well-being, 2) patient physical and psychosocial outcomes, and 3) health services utilization and costs. Palliative care focuses on providing patients with serious illnesses and their families with physical, emotional, social, practical, and spiritual support. Recent trials examining the integration of palliative care in cancer care have individually shown improvement in patient symptoms and quality of life, reduction of caregiver burden, and/or health services costs. These studies, however, have not collectively analyzed these impacts.Further, a recent study shows that integrating palliative care early in lung cancer care has proven beneficial to both patients and caregivers. Given the potential of this previous body of research, the proposed study offers a comprehensive analysis of the early integration of palliative care on caregiver well-being, patient's physical and psychosocial outcomes when living with liver and metastatic colorectal cancer (mCRC), and health services utilization. This study thus broadens the scope to additional cancer types and degrees of progression.

Interventions

The intervention group- will include 30 patients receiving treatment by the Interventional Radiology team along with their primary caregiver. Patients and caregivers will receive a brief palliative care training intervention during their first follow-up visit. Patients and their caregivers will receive questionnaires to assess their health status (physical and psychosocial) and health services utilization outcomes at 1, 2, and 3 months post-procedure during their follow-up visits.

Sponsors

University of Miami
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

The present study is a randomized single-center therapeutic clinical trial including the following two prospective groups: Control group and the intervention group.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- Patients over 18 years of age with a confirmed diagnosis of liver cancer or metastatic colorectal cancer requiring treatment from the IR team.

Exclusion criteria

\- None

Design outcomes

Primary

MeasureTime frameDescription
Changes in Edmonton Symptom Assessment Score (ESAS-R)1, 2 and 3 monthsMeasure the impact of an early palliative care intervention on patient physical and psychosocial outcomes. The early integration of palliative care at diagnosis or immediately post- procedure, will improve patients' physical and psychosocial symptoms. The score of such assessment should decrease from baseline as the result of the intervention.

Secondary

MeasureTime frameDescription
Measure of the Eastern Cooperative Oncology Group (ECOG) performance Status1, 2 and 3 monthsMeasure the decrease of the ECOG status as a result of the proposed intervention.

Other

MeasureTime frameDescription
Measure the decrease in the score of the Center for Epidemiologic Studies Depression Scale (CES-D).1, 2 and 3 monthsIt is anticipated that the CES-D score will be decreased from baseline as a result of the proposed intervention.
Caregiver Well-being Scale1, 2 and 3 monthsThe caregiver well-being Scale will measure the Caregiver Well-Being.
Health services costs1, 2 and 3 monthsSubsequent to the integration of palliative care resulting in improved patient outcomes, the frequency of ED visits, ICU visits, and hospital stays will decrease and therefore reduce costs.
Health services utilization1, 2 and 3 monthsSubsequent to the integration of palliative care resulting in improved patient outcomes, the frequency of ED visits, ICU visits, and hospital stays will decrease.
Caregiver Quality of Life-Cancer Scale1, 2 and 3 monthsThe caregiver Quality of Life-Cancer Scale will measure the quality of life of subjects with cancer.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026